A Study Comparing Efficacy Of First-Line-Regimens Containing Abacavir With Lamivudine (ABC/3TC) Or Tenofovir With Emtricitabine (TDF/FTC) In Patients With A High Viral Load.

Trial Profile

A Study Comparing Efficacy Of First-Line-Regimens Containing Abacavir With Lamivudine (ABC/3TC) Or Tenofovir With Emtricitabine (TDF/FTC) In Patients With A High Viral Load.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Feb 2017

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lamivudine/abacavir (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top